Literature DB >> 15218804

Natural history of primary progressive multiple sclerosis.

George C Ebers1.   

Abstract

The relationship of primary progressive multiple sclerosis (PPMS) to relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) remains unclear. Natural history data from a population-based cohort of patients with PPMS followed for approximately 25 years demonstrate remarkable similarities in the progressive phases of PPMS and SPMS. Immunogenetic and magnetic resonance imaging studies in large numbers of patients also fail to differentiate between the two MS categories. PPMS thus resembles SPMS without the relapses, although the two forms do differ with respect to sex ratio. An unfavourable outcome in PPMS in predicted by rapid early progression of disability and involvement of three or more systems. Natural history studies provide information on likely long-term outcomes and can be used in the design and interpretation of clinical trials in PPMS. The evidence that PPMS is distinct remains weak.

Entities:  

Mesh:

Year:  2004        PMID: 15218804     DOI: 10.1191/1352458504ms1025oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  19 in total

1.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 2.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

3.  Progressive multiple sclerosis and mood disorders.

Authors:  Lorena Lorefice; G Fenu; G Trincas; M F Moro; J Frau; G C Coghe; E Cocco; M G Marrosu; M G Carta
Journal:  Neurol Sci       Date:  2015-04-22       Impact factor: 3.307

4.  Determinants of Disability in Progressive Onset Multiple Sclerosis.

Authors:  Melih Tütüncü; Mesude Tütüncü; Sabahattin Saip; Aksel Siva
Journal:  Noro Psikiyatr Ars       Date:  2020-06-09       Impact factor: 1.339

5.  Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.

Authors:  M Debouverie; S Louis; S Pittion-Vouyovitch; T Roederer; H Vespignani
Journal:  J Neurol       Date:  2007-06-25       Impact factor: 4.849

6.  Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.

Authors:  Clara Guaschino; Federica Esposito; Giuseppe Liberatore; Bruno Colombo; Pietro Annovazzi; Emanuele D'Amico; Paola Cavalla; Elisabetta Capello; Ruggero Capra; Daniela Galimberti; Gioacchino Tedeschi; Luigi Grimaldi; Maurizio Leone; Sandra D'Alfonso; Vittorio Martinelli; Giancarlo Comi; Filippo Martinelli-Boneschi
Journal:  Neurol Sci       Date:  2014-02-11       Impact factor: 3.307

7.  Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.

Authors:  Chulbul M Ahmed; Ezra N Noon-Song; Kaisa Kemppainen; Massimo P Pascalli; Howard M Johnson
Journal:  J Neuroimmunol       Date:  2012-10-27       Impact factor: 3.478

Review 8.  The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Authors:  Giulia Mallucci; Luca Peruzzotti-Jametti; Joshua D Bernstock; Stefano Pluchino
Journal:  Prog Neurobiol       Date:  2015-03-21       Impact factor: 11.685

Review 9.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

10.  Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.

Authors:  Jun Yan; Jia Liu; Clement Yihao Lin; Peter A Csurhes; Michael P Pender; Pamela A McCombe; Judith M Greer
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.